{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:47:17Z","timestamp":1771660037338,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,9,5]],"date-time":"2010-09-05T00:00:00Z","timestamp":1283644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10096-010-1033-9","type":"journal-article","created":{"date-parts":[[2010,9,3]],"date-time":"2010-09-03T23:56:18Z","timestamp":1283558178000},"page":"1513-1523","source":"Crossref","is-referenced-by-count":7,"title":["Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains"],"prefix":"10.1007","volume":"29","author":[{"given":"V.","family":"Pliaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Kyriakopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Tsakogiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. G. A.","family":"Ruether","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gartzonika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Levidiotou-Stefanou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Krikelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Markoulatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,5]]},"reference":[{"key":"1033_CR1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.ge.27.120193.002033","volume":"27","author":"E Wimmer","year":"1993","unstructured":"Wimmer E, Hellen CUT, Cao X (1993) Genetics of poliovirus. Annu Rev Genet 27:353\u2013436","journal-title":"Annu Rev Genet"},{"key":"1033_CR2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0042-6822(89)90259-6","volume":"168","author":"EV Pilipenko","year":"1989","unstructured":"Pilipenko EV, Blinov VM, Romanova LI, Sinyakov AN, Maslova SV, Agol VI (1989) Conserved structural domains in the 5\u2032-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence. Virology 168:201\u2013209","journal-title":"Virology"},{"key":"1033_CR3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0022-2836(89)90261-1","volume":"207","author":"MA Skinner","year":"1989","unstructured":"Skinner MA, Racaniello VR, Dunn G, Cooper J, Minor PD, Almond JW (1989) New model for the secondary structure of the 5\u2032 non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J Mol Biol 207:379\u2013392","journal-title":"J Mol Biol"},{"key":"1033_CR4","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1128\/MCB.8.3.1103","volume":"8","author":"J Pelletier","year":"1988","unstructured":"Pelletier J, Kaplan G, Racaniello VR, Sonenberg N (1988) Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5\u2032 noncoding region. Mol Cell Biol 8:1103\u20131112","journal-title":"Mol Cell Biol"},{"key":"1033_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0092-1157(73)90048-6","volume":"1","author":"AB Sabin","year":"1973","unstructured":"Sabin AB, Boulger LR (1973) History of Sabin attenuated poliovirus oral live vaccine strains. J Biol Stand 1:115\u2013118","journal-title":"J Biol Stand"},{"key":"1033_CR6","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1128\/JVI.64.10.4922-4929.1990","volume":"64","author":"C Christodoulou","year":"1990","unstructured":"Christodoulou C, Colbere-Garapin F, Macadam A, Taffs LF, Marsden S, Minor P, Horaud F (1990) Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J Virol 64:4922\u20134929","journal-title":"J Virol"},{"key":"1033_CR7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0042-6822(89)90183-9","volume":"172","author":"AJ Macadam","year":"1989","unstructured":"Macadam AJ, Arnold C, Howlett J, John A, Marsden S, Taffs F, Reeve P, Hamada N, Wareham K, Almond J, Cammack N, Minor PD (1989) Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology 172:408\u2013414","journal-title":"Virology"},{"key":"1033_CR8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0042-6822(91)90877-E","volume":"181","author":"AJ Macadam","year":"1991","unstructured":"Macadam AJ, Pollard SR, Ferguson G, Dunn G, Skuce R, Almond JW, Minor PD (1991) The 5\u2032 noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology 181:451\u2013458","journal-title":"Virology"},{"key":"1033_CR9","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/JVI.69.8.4972-4978.1995","volume":"69","author":"MJ Bouchard","year":"1995","unstructured":"Bouchard MJ, Lam DH, Racaniello VR (1995) Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol 69:4972\u20134978","journal-title":"J Virol"},{"key":"1033_CR10","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1128\/JVI.69.9.5278-5286.1995","volume":"69","author":"MM Georgescu","year":"1995","unstructured":"Georgescu MM, Tardy-Panit M, Guillot S, Crainic R, Delpeyroux F (1995) Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus. J Virol 69:5278\u20135286","journal-title":"J Virol"},{"key":"1033_CR11","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1128\/JVI.63.3.1302-1309.1989","volume":"63","author":"N Kawamura","year":"1989","unstructured":"Kawamura N, Kohara M, Abe S, Komatsu T, Tago K, Arita M, Nomoto A (1989) Determinants in the 5\u2032 noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol 63:1302\u20131309","journal-title":"J Virol"},{"key":"1033_CR12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/JVI.58.2.348-358.1986","volume":"58","author":"T Omata","year":"1986","unstructured":"Omata T, Kohara M, Kuge S, Komatsu T, Abe S, Semler BL, Kameda A, Itoh H, Arita M, Wimmer E, Nomoto A (1986) Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol 58:348\u2013358","journal-title":"J Virol"},{"key":"1033_CR13","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1128\/JVI.67.8.4630-4638.1993","volume":"67","author":"M Tardy-Panit","year":"1993","unstructured":"Tardy-Panit M, Blondel B, Martin A, Tekaia F, Horaud F, Delpeyroux F (1993) A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice. J Virol 67:4630\u20134638","journal-title":"J Virol"},{"key":"1033_CR14","first-page":"33","volume":"78","author":"D Otelea","year":"1993","unstructured":"Otelea D, Guillot S, Furione M, Combiescu AA, Balanant J, Candrea A, Crainic R (1993) Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses. Dev Biol Stand 78:33\u201338","journal-title":"Dev Biol Stand"},{"issue":"1","key":"1033_CR15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/164.1.191","volume":"164","author":"PL Ogra","year":"1991","unstructured":"Ogra PL, Faden HS, Abraham R, Duffy LC, Sun M, Minor PD (1991) Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. J Infect Dis 164(1):191\u2013194","journal-title":"J Infect Dis"},{"key":"1033_CR16","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1099\/0022-1317-70-5-1117","volume":"70","author":"PD Minor","year":"1989","unstructured":"Minor PD, Dunn G, Evans DM, Magrath DI, John A, Howlett J, Phillips A, Westrop G, Wareham K, Almond JW, Hogle JM (1989) The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3. J Gen Virol 70:1117\u20131123","journal-title":"J Gen Virol"},{"key":"1033_CR17","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1128\/JVI.63.3.1338-1344.1989","volume":"63","author":"GD Westrop","year":"1989","unstructured":"Westrop GD, Wareham KA, Evans DM, Dunn G, Minor PD, Magrath DI, Taffs F, Marsden S, Skinner MA, Schild GC, Almond JW (1989) Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol 63:1338\u20131344","journal-title":"J Virol"},{"key":"1033_CR18","doi-asserted-by":"crossref","first-page":"11097","DOI":"10.1128\/JVI.78.20.11097-11107.2004","volume":"78","author":"S Guest","year":"2004","unstructured":"Guest S, Pilipenko E, Sharma K, Chumakov K, Roos RP (2004) Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3. J Virol 78:11097\u201311107","journal-title":"J Virol"},{"key":"1033_CR19","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1128\/JVI.71.5.3826-3833.1997","volume":"71","author":"AL Guti\u00e9rrez","year":"1997","unstructured":"Guti\u00e9rrez AL, Denova-Ocampo M, Racaniello VR, del Angel RM (1997) Attenuating mutations in the poliovirus 5\u2032 untranslated region alter its interaction with polypyrimidine tract-binding protein. J Virol 71:3826\u20133833","journal-title":"J Virol"},{"issue":"6011","key":"1033_CR20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/314548a0","volume":"314","author":"DM Evans","year":"1985","unstructured":"Evans DM, Dunn G, Minor PD, Schild GC, Cann AJ, Stanway G, Almond JW, Currey K, Maizel JV Jr (1985) Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature 314(6011):548\u2013550","journal-title":"Nature"},{"issue":"8","key":"1033_CR21","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1128\/JCM.02268-06","volume":"45","author":"D Gnanashanmugam","year":"2007","unstructured":"Gnanashanmugam D, Falkovitz-Halpern MS, Dodge A, Fang M, Wong LJ, Esparza M, Hammon R, Rivas-Merelles EE, Santos JI, Maldonado Y (2007) Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay. J Clin Microbiol 45(8):2419\u20132425","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1033_CR22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1086\/421703","volume":"190","author":"CV Martinez","year":"2004","unstructured":"Martinez CV, Old MO, Kwock DK, Khan SS, Garcia JJ, Chan CS, Webster R, Falkovitz-Halpern MS, Maldonado YA (2004) Shedding of sabin poliovirus Type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine. J Infect Dis 190(2):409\u2013416","journal-title":"J Infect Dis"},{"key":"1033_CR23","first-page":"1","volume":"46","author":"Centers for Disease Control and Prevention (CDC)","year":"1997","unstructured":"Centers for Disease Control and Prevention (CDC) (1997) Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 46:1\u201325","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1033_CR24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/viro.1993.1468","volume":"196","author":"M Furione","year":"1993","unstructured":"Furione M, Guillot S, Otelea D, Balanant J, Candrea A, Crainic R (1993) Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology 196:199\u2013208","journal-title":"Virology"},{"key":"1033_CR25","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1128\/JVI.71.10.7758-7768.1997","volume":"71","author":"MM Georgescu","year":"1997","unstructured":"Georgescu MM, Balanant J, Macadam A, Otelea D, Combiescu M, Combiescu AA, Crainic R, Delpeyroux F (1997) Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis. J Virol 71:7758\u20137768","journal-title":"J Virol"},{"key":"1033_CR26","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/JVI.79.2.1062-1070.2005","volume":"79","author":"EA Cherkasova","year":"2005","unstructured":"Cherkasova EA, Yakovenko ML, Rezapkin GV, Korotkova EA, Ivanova OE, Eremeeva TP, Krasnoproshina LI, Romanenkova NI, Rozaeva NR, Sirota L, Agol VI, Chumakov KM (2005) Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine. J Virol 79:1062\u20131070","journal-title":"J Virol"},{"issue":"7","key":"1033_CR27","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/JVI.02122-08","volume":"83","author":"ML Yakovenko","year":"2009","unstructured":"Yakovenko ML, Korotkova EA, Ivanova OE, Eremeeva TP, Samoilovich E, Uhova I, Gavrilin GV, Agol VI (2009) Evolution of the Sabin vaccine into pathogenic derivatives without appreciable changes in antigenic properties: need for improvement of current poliovirus surveillance. J Virol 83(7):3402\u20133406","journal-title":"J Virol"},{"key":"1033_CR28","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1128\/JCM.38.12.4337-4342.2000","volume":"38","author":"A Georgopoulou","year":"2000","unstructured":"Georgopoulou A, Markoulatos P, Spyrou N, Vamvakopoulos NC (2000) Improved genotyping vaccine and wild-type poliovirus strains by restriction fragment length polymorphism analysis: clinical diagnostic implications. J Clin Microbiol 38:4337\u20134342","journal-title":"J Clin Microbiol"},{"key":"1033_CR29","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0042-6822(91)90434-D","volume":"184","author":"J Balanant","year":"1991","unstructured":"Balanant J, Guillot S, Candrea A, Delpeyroux F, Crainic R (1991) The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology 184:645\u2013654","journal-title":"Virology"},{"key":"1033_CR30","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1099\/0022-1317-80-4-907","volume":"80","author":"MN Mulders","year":"1999","unstructured":"Mulders MN, Reimerink JH, Stenvik M, Alaeddinoglu I, van der Avoort HG, Hovi T, Koopmans MP (1999) A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1. J Gen Virol 80:907\u2013916","journal-title":"J Gen Virol"},{"key":"1033_CR31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11262-005-0055-3","volume":"33","author":"E Dedepsidis","year":"2006","unstructured":"Dedepsidis E, Karakasiliotis I, Paximadi E, Kyriakopoulou Z, Komiotis D, Markoulatos P (2006) Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine. Virus Genes 33:183\u2013191","journal-title":"Virus Genes"},{"key":"1033_CR32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mcp.2003.09.009","volume":"18","author":"I Karakasiliotis","year":"2004","unstructured":"Karakasiliotis I, Markoulatos P, Katsorchis T (2004) Site analysis of recombinant and mutant poliovirus isolates of Sabin origin from patients and from vaccinees. Mol Cell Probes 18:103\u2013109","journal-title":"Mol Cell Probes"},{"key":"1033_CR33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11262-005-6877-1","volume":"32","author":"E Paximadi","year":"2006","unstructured":"Paximadi E, Karakasiliotis I, Mamuris Z, Stathopoulos C, Krikelis V, Markoulatos P (2006) Genomic analysis of recombinant sabin clinical isolates. Virus Genes 32:203\u2013210","journal-title":"Virus Genes"},{"key":"1033_CR34","first-page":"178","volume":"24","author":"JH Nakano","year":"1978","unstructured":"Nakano JH, Hatch MH, Thieme ML, Nottay B (1978) Parameters for differentiating vaccine-derived and wild poliovirus strains. Prog Med Virol 24:178\u2013206","journal-title":"Prog Med Virol"},{"issue":"21","key":"1033_CR35","doi-asserted-by":"crossref","first-page":"10617","DOI":"10.1128\/JVI.76.21.10617-10626.2002","volume":"76","author":"CE Malnou","year":"2002","unstructured":"Malnou CE, P\u00f6yry TA, Jackson RJ, Kean KM (2002) Poliovirus internal ribosome entry segment structure alterations that specifically affect function in neuronal cells: molecular genetic analysis. J Virol 76(21):10617\u201310626","journal-title":"J Virol"},{"key":"1033_CR36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1006\/viro.1994.1353","volume":"202","author":"GV Rezapkin","year":"1994","unstructured":"Rezapkin GV, Chumakov KM, Lu Z, Ran Y, Dragunsky EM, Levenbook IS (1994) Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine. Virology 202:370\u2013378","journal-title":"Virology"},{"key":"1033_CR37","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1128\/JVI.76.13.6791-6799.2002","volume":"76","author":"EA Cherkasova","year":"2002","unstructured":"Cherkasova EA, Korotkova EA, Yakovenko ML, Ivanova OE, Eremeeva TP, Chumakov KM, Agol VI (2002) Long-term circulation of vaccine-derived poliovirus that causes paralytic disease. J Virol 76:6791\u20136799","journal-title":"J Virol"},{"key":"1033_CR38","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1099\/0022-1317-67-7-1283","volume":"67","author":"PD Minor","year":"1986","unstructured":"Minor PD, Ferguson M, Evans DM, Almond JW, Icenogle JP (1986) Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol 67:1283\u20131291","journal-title":"J Gen Virol"},{"key":"1033_CR39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1006\/viro.1995.0067","volume":"214","author":"J Harber","year":"1995","unstructured":"Harber J, Bernhardt G, Lu HH, Sgro JY, Wimmer E (1995) Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor. Virology 214:559\u2013570","journal-title":"Virology"},{"key":"1033_CR40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1073\/pnas.97.1.79","volume":"97","author":"Y He","year":"2000","unstructured":"He Y, Bowman VD, Mueller S, Bator CM, Bella J, Peng X, Baker TS, Wimmer E, Kuhn RJ, Rossmann MG (2000) Interaction of the poliovirus receptor with poliovirus. Proc Natl Acad Sci USA 97:79\u201384","journal-title":"Proc Natl Acad Sci USA"},{"key":"1033_CR41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0168-1702(91)90002-D","volume":"21","author":"AR Muzychenko","year":"1991","unstructured":"Muzychenko AR, Lipskaya GYu, Maslova SV, Svitkin YV, Pilipenko EV, Nottay BK, Kew OM, Agol VI (1991) Coupled mutations in the 5\u2032-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications. Virus Res 21:111\u2013122","journal-title":"Virus Res"},{"key":"1033_CR42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/viro.1993.1003","volume":"192","author":"AJ Macadam","year":"1993","unstructured":"Macadam AJ, Pollard SR, Ferguson G, Skuce R, Wood D, Almond JW, Minor PD (1993) Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology 192:18\u201326","journal-title":"Virology"},{"key":"1033_CR43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/biol.1993.1096","volume":"21","author":"PD Minor","year":"1993","unstructured":"Minor PD, Macadam AJ, Stone DM, Almond JW (1993) Genetic basis of attenuation of the Sabin oral poliovirus vaccines. Biologicals 21:357\u2013363","journal-title":"Biologicals"},{"key":"1033_CR44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0264-410X(94)90307-7","volume":"12","author":"S Guillot","year":"1994","unstructured":"Guillot S, Otelea D, Delpeyroux F, Crainic R (1994) Point mutations involved in the attenuation\/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction. Vaccine 12:503\u2013507","journal-title":"Vaccine"},{"key":"1033_CR45","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1128\/JVI.68.12.8089-8101.1994","volume":"68","author":"MM Georgescu","year":"1994","unstructured":"Georgescu MM, Delpeyroux F, Tardy-Panit M, Balanant J, Combiescu M, Combiescu AA, Guillot S, Crainic R (1994) High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J Virol 68:8089\u20138101","journal-title":"J Virol"},{"key":"1033_CR46","first-page":"157","volume":"40","author":"F Friedrich","year":"1996","unstructured":"Friedrich F (1996) Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees. Acta Virol 40:157\u2013170","journal-title":"Acta Virol"},{"key":"1033_CR47","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1128\/JVI.65.5.2707-2710.1991","volume":"65","author":"M Equestre","year":"1991","unstructured":"Equestre M, Genovese D, Cavalieri F, Fiore L, Santoro R, Perez Bercoff R (1991) Identification of a consistent pattern of mutations in neurovirulent variants derived from the sabin vaccine strain of poliovirus type 2. J Virol 65:2707\u20132710","journal-title":"J Virol"},{"key":"1033_CR48","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1128\/JVI.61.9.2917-2920.1987","volume":"61","author":"N Monica La","year":"1987","unstructured":"La Monica N, Almond JW, Racaniello VR (1987) A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans. J Virol 61:2917\u20132920","journal-title":"J Virol"},{"key":"1033_CR49","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1128\/JVI.63.5.2357-2360.1989","volume":"63","author":"N Monica La","year":"1989","unstructured":"La Monica N, Racaniello VR (1989) Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J Virol 63:2357\u20132360","journal-title":"J Virol"},{"key":"1033_CR50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1073\/pnas.88.1.199","volume":"88","author":"KM Chumakov","year":"1991","unstructured":"Chumakov KM, Powers LB, Noonan KE, Roninson IB, Levenbook IS (1991) Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc Natl Acad Sci USA 88:199\u2013203","journal-title":"Proc Natl Acad Sci USA"},{"key":"1033_CR51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.mcp.2007.01.004","volume":"21","author":"V Pliaka","year":"2007","unstructured":"Pliaka V, Dedepsidis E, Kyriakopoulou Z, Papadopoulou I, Levidiotou S, Markoulatos P (2007) Use of mutational pattern in 5\u2032-NCR and VP1 regions of polioviruses for molecular diagnosis. Mol Cell Probes 21:267\u2013275","journal-title":"Mol Cell Probes"},{"issue":"2","key":"1033_CR52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11262-010-0448-9","volume":"40","author":"V Pliaka","year":"2010","unstructured":"Pliaka V, Dedepsidis E, Kyriakopoulou Z, Papadi G, Tsakogiannis D, Pratti A, Levidiotou-Stefanou S, Markoulatos P (2010) Growth kinetic analysis of bi-recombinant poliovirus vaccine strains. Virus Genes 40(2):200\u2013211","journal-title":"Virus Genes"},{"key":"1033_CR53","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/0042-6822(91)90576-W","volume":"185","author":"C Weeks-Levy","year":"1991","unstructured":"Weeks-Levy C, Tatem JM, DiMichele SJ, Waterfield W, Georgiu AF, Mento SJ (1991) Identification and characterization of a new base substitution in the vaccine strain of Sabin 3 poliovirus. Virology 185:934\u2013937","journal-title":"Virology"},{"key":"1033_CR54","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1128\/JVI.66.5.3194-3197.1992","volume":"66","author":"JM Tatem","year":"1992","unstructured":"Tatem JM, Weeks-Levy C, Georgiu A, DiMichele SJ, Gorgacz EJ, Racaniello VR, Cano FR, Mento SJ (1992) A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating. J Virol 66:3194\u20133197","journal-title":"J Virol"},{"key":"1033_CR55","first-page":"93","volume":"78","author":"SJ Mento","year":"1993","unstructured":"Mento SJ, Weeks-Levy C, Tatem JM, Gorgacz EJ, Waterfield WF (1993) Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine. Dev Biol Stand 78:93\u2013100","journal-title":"Dev Biol Stand"},{"key":"1033_CR56","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/JVI.64.5.1934-1945.1990","volume":"64","author":"CE Fricks","year":"1990","unstructured":"Fricks CE, Hogle JM (1990) Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. J Virol 64:1934\u20131945","journal-title":"J Virol"},{"key":"1033_CR57","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0042-6822(91)90078-P","volume":"180","author":"A Martin","year":"1991","unstructured":"Martin A, Benichou D, Couderc T, Hogle JM, Wychowski C, Van der Werf S, Girard M (1991) Use of type 1\/type 2 chimeric polioviruses to study determinants of poliovirus type 1 neurovirulence in a mouse model. Virology 180:648\u2013658","journal-title":"Virology"},{"key":"1033_CR58","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1128\/JVI.69.12.7601-7605.1995","volume":"69","author":"A McGoldrick","year":"1995","unstructured":"McGoldrick A, Macadam AJ, Dunn G, Rowe A, Burlison J, Minor PD, Meredith J, Evans DJ, Almond JW (1995) Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus. J Virol 69:7601\u20137605","journal-title":"J Virol"},{"key":"1033_CR59","doi-asserted-by":"crossref","first-page":"10359","DOI":"10.1128\/JVI.74.22.10359-10370.2000","volume":"74","author":"AV Paul","year":"2000","unstructured":"Paul AV, Rieder E, Kim DW, van Boom JH, Wimmer E (2000) Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J Virol 74:10359\u201310370","journal-title":"J Virol"},{"key":"1033_CR60","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1128\/JVI.74.22.10371-10380.2000","volume":"74","author":"E Rieder","year":"2000","unstructured":"Rieder E, Paul AV, Kim DW, van Boom JH, Wimmer E (2000) Genetic and biochemical studies of poliovirus cis-acting replication element cre in relation to VPg uridylylation. J Virol 74:10371\u201310380","journal-title":"J Virol"},{"key":"1033_CR61","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1128\/JVI.78.24.13839-13847.2004","volume":"78","author":"J Mart\u00edn","year":"2004","unstructured":"Mart\u00edn J, Odoom K, Tuite G, Dunn G, Hopewell N, Cooper G, Fitzharris C, Butler K, Hall WW, Minor PD (2004) Long-term excretion of vaccine-derived poliovirus by a healthy child. J Virol 78:13839\u201313847","journal-title":"J Virol"},{"key":"1033_CR62","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jmv.10224","volume":"68","author":"H Horie","year":"2002","unstructured":"Horie H, Yoshida H, Matsuura K, Miyazawa M, Wakabayashi K, Nomoto A, Hashizume S (2002) Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan. J Med Virol 68:445\u2013451","journal-title":"J Med Virol"},{"key":"1033_CR63","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/jmv.21063","volume":"80","author":"J Cello","year":"2008","unstructured":"Cello J, Toyoda H, Dejesus N, Dobrikova EY, Gromeier M, Wimmer E (2008) Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio\/human rhinoviruses. J Med Virol 80:352\u2013359","journal-title":"J Med Virol"},{"key":"1033_CR64","doi-asserted-by":"crossref","first-page":"10261","DOI":"10.1074\/jbc.M307806200","volume":"279","author":"CE Malnou","year":"2004","unstructured":"Malnou CE, Werner A, Borman AM, Westhof E, Kean KM (2004) Effects of vaccine strain mutations in domain V of the internal ribosome entry segment compared in the wild type poliovirus type 1 context. J Biol Chem 279:10261\u201310269","journal-title":"J Biol Chem"},{"key":"1033_CR65","doi-asserted-by":"crossref","first-page":"14235","DOI":"10.1128\/JVI.79.22.14235-14243.2005","volume":"79","author":"N Jesus De","year":"2005","unstructured":"De Jesus N, Franco D, Paul A, Wimmer E, Cello J (2005) Mutation of a single conserved nucleotide between the cloverleaf and internal ribosome entry site attenuates poliovirus neurovirulence. J Virol 79:14235\u201314243","journal-title":"J Virol"},{"key":"1033_CR66","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/clinids\/14.2.568","volume":"14","author":"PM Strebel","year":"1992","unstructured":"Strebel PM, Sutter RW, Cochi SL, Biellik RJ, Brink EW, Kew OM, Pallansch MA, Orenstein WA, Hinman AR (1992) Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis 14:568\u2013579","journal-title":"Clin Infect Dis"},{"key":"1033_CR67","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/oxfordjournals.aje.a117211","volume":"140","author":"PM Strebel","year":"1994","unstructured":"Strebel PM, Aubert-Combiescu A, Ion-Nedelcu N, Biberi-Moroeanu S, Combiescu M, Sutter RW, Kew OM, Pallansch MA, Patriarca PA, Cochi SL (1994) Paralytic poliomyelitis in Romania, 1984\u20131992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol 140:1111\u20131124","journal-title":"Am J Epidemiol"},{"key":"1033_CR68","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1128\/JVI.75.13.5740-5751.2001","volume":"75","author":"NS Cuervo","year":"2001","unstructured":"Cuervo NS, Guillot S, Romanenkova N, Combiescu M, Aubert-Combiescu A, Seghier M, Caro V, Crainic R, Delpeyroux F (2001) Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees. J Virol 75:5740\u20135751","journal-title":"J Virol"},{"key":"1033_CR69","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/BF01720298","volume":"11","author":"G Driesel","year":"1995","unstructured":"Driesel G, Diedrich S, Kunkel U, Schreier E (1995) Vaccine-associated cases of poliomyelitis over a 30\u00a0year period in East Germany. Eur J Epidemiol 11:647\u2013654","journal-title":"Eur J Epidemiol"},{"key":"1033_CR70","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1128\/JVI.74.16.7381-7390.2000","volume":"74","author":"GV Gavrilin","year":"2000","unstructured":"Gavrilin GV, Cherkasova EA, Lipskaya GY, Kew OM, Agol VI (2000) Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J Virol 74:7381\u20137390","journal-title":"J Virol"},{"issue":"Pt 8","key":"1033_CR71","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1099\/vir.0.010942-0","volume":"90","author":"C Savolainen-Kopra","year":"2009","unstructured":"Savolainen-Kopra C, Samoilovich E, Kahelin H, Hiekka AK, Hovi T, Roivainen M (2009) Comparison of poliovirus recombinants: accumulation of point mutations provides further advantages. J Gen Virol 90(Pt 8):1859\u20131868","journal-title":"J Gen Virol"},{"issue":"7","key":"1033_CR72","first-page":"733","volume":"28","author":"F Friedrich","year":"1995","unstructured":"Friedrich F, Filippis AM, Ferreira FC, Schatzmayr HG, Da-Silva EE (1995) Genomic characterization of type 2 polioviruses isolated from vaccine-associated cases in Brazil. Braz J Med Biol Res 28(7):733\u2013742","journal-title":"Braz J Med Biol Res"},{"key":"1033_CR73","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1099\/vir.0.18708-0","volume":"84","author":"S Blomqvist","year":"2003","unstructured":"Blomqvist S, Bruu AL, Stenvik M, Hovi T (2003) Characterization of a recombinant type 3\/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. J Gen Virol 84:573\u2013580","journal-title":"J Gen Virol"},{"key":"1033_CR74","doi-asserted-by":"crossref","first-page":"10921","DOI":"10.1128\/JVI.76.21.10921-10928.2002","volume":"76","author":"J Mart\u00edn","year":"2002","unstructured":"Mart\u00edn J, Samoilovich E, Dunn G, Lackenby A, Feldman E, Heath A, Svirchevskaya E, Cooper G, Yermalovich M, Minor PD (2002) Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis. J Virol 76:10921\u201310928","journal-title":"J Virol"},{"key":"1033_CR75","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11262-007-0146-4","volume":"35","author":"E Paximadi","year":"2007","unstructured":"Paximadi E, Karakasiliotis I, Bolanaki E, Krikelis A, Markoulatos P (2007) Vaccine derived bi- and multi-recombinant Sabin strains. Virus Genes 35:541\u2013548","journal-title":"Virus Genes"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1033-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-010-1033-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1033-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T06:52:58Z","timestamp":1591858378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-010-1033-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,5]]},"references-count":75,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1033"],"URL":"https:\/\/doi.org\/10.1007\/s10096-010-1033-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,5]]}}}